George F.
- Country
- Greece
- Department
- Oncology Department
Research Overview
- Evaluation of Geriatric Assessment-Guided Dose Optimization of CDK 4/6 Inhibitors in Vulnerable Elderly Patients with Advanced Breast Cancer
- Phase 2/3 Multicenter Randomized Study of Raludotatug Deruxtecan in Platinum-Resistant High-Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Phase III Multicenter Study Comparing Entrectinib and Crizotinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer with CNS Metastases
Data & Insights
Has run more than one trial at 206 of 429 partner sites.
Specializations
Lung Cancer Expertise
This investigator specializes in non-small cell lung cancer (NSCLC) treatment and research, with particular focus on advanced disease stages including Stage IIB, IIIA, and IIIB presentations.
- Post-surgical treatment strategies
- Adjuvant therapy protocols
- PD-L1 positive cancer management
Their work encompasses comprehensive treatment approaches following surgical resection and platinum-based chemotherapy.
Precision Oncology
The investigator focuses on targeted therapies for ROS1-positive NSCLC, addressing specific genetic alterations in lung cancer patients. Their expertise extends to treating cases with central nervous system (CNS) metastases.
- ROS1 rearrangement-positive cancer treatment
- Advanced metastatic disease management
- Targeted therapeutic approaches
Their research interests include comparative assessment of targeted therapies in metastatic disease settings.
Immunotherapy Applications
The investigator explores innovative immunotherapy combinations in lung cancer treatment, focusing on immune checkpoint inhibition and novel therapeutic partnerships.
- Combination immunotherapy strategies
- Safety profile evaluation
- Treatment optimization protocols
Their work encompasses the development of new therapeutic approaches in immunotherapy-based treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.